Not a good buy right now: price is in a clear downtrend (bearish MA stack) and has slipped below the near support area.
No Intellectia buy signals today (AI Stock Picker/SwingMax), so there’s no tactical edge for an immediate entry.
With no fresh news catalysts and weak/flat fundamentals (losses persist, EPS down), the setup favors avoiding or exiting rather than buying now—especially for an impatient investor.
RSI(6): ~27.1 (oversold/washed-out). This can produce short bounces, but oversold alone is not a buy signal when the broader trend is bearish.
MACD: Histogram positive (0.0216) but contracting—bullish momentum is fading rather than accelerating.
Key levels: Current price 3.45 is below S1 (3.505), suggesting a breakdown; next notable support is S2 at 3.066. Upside recovery targets are Pivot 4.216 then R1 4.926.
Pattern-based forward drift (similar candles): Slight negative bias (-0.27% next day, -1.57% next week, -1.6% next month), aligning with the bearish trend.
Positive Catalysts
Potential technical bounce risk exists because RSI is oversold (short-lived mean reversion possible).
No notable insider or hedge fund selling pressure indicated (both neutral), reducing the chance of an “accelerant” from positioning shifts.
Neutral/Negative Catalysts
increases probability of a move toward S2 (3.066).
Gross margin: 80.8 (0.00% YoY) — strong margin on paper, but it’s not translating into profitability given ongoing net losses.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating/price target change data provided, so a current Wall Street pro/con consensus cannot be validated from the dataset.
Practical takeaway: absent analyst support/trend data, the decision leans more heavily on the clearly bearish technicals and weak earnings trajectory.
Influential/political flows: No recent congress trading data available (last 90 days).
Wall Street analysts forecast NOMA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NOMA is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Analyst Rating
0
Wall Street analysts forecast NOMA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NOMA is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
